Prevention of bone loss and fractures in women.
D000367:Age Factors; D000368:Aged; D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D002118:Calcium / Q000378:metabolism / Q000627:therapeutic use; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use; D009929:Organ Size; D010024:Osteoporosis / Q000517:prevention & control*; D010758:Phosphorus / Q000378:metabolism; D044469:Racial Groups; D012737:Sex Factors; D014594:Uterine Neoplasms / Q000139:chemically induced
D004967:Estrogens; D010758:Phosphorus; D002118:Calcium; D009640:Norethindrone